Abstract
Important progress has been made during the past few years in the understanding of putative successes and failures of oral anticoagulation (OAC) in general, and in the secondary prevention of myocardial infarction in particular. Not only did the conception of thrombotic pathogenesis of the transmural type of myocardial infarction revive after successful removal of acute coronary obstruction by the use of streptokinase, a thrombolytic agent (Loeliger 1981); the results of the Dutch Sixty-Plus Reinfarction Study, which showed a significantly better prognosis for patients given continued oral anticoagulant therapy (Sixty-Plus Reinfarction Study Research Group 1980), reopened the discussion about oral anticoagulants in myocardial infarction (Mitchell 1981). It became clear that strict adherence to a well-defined therapeutic range (Poller 1982), therapeutic quality control (Duxbury 1982), and standardization of the prothrombin time (Loeliger and Lewis 1982) were essential for successful anticoagulation; in their absence such treatment is doomed to failure (Loeliger 1981).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Altman R, Boullon F, Raca R, et al. (1976) Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg 72: 127
AMIS Research Group (1980) A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 243: 661
Aspenstrøm G, Korsan-Bengtsen K (1964) A double blind study of dicumarol prophylaxis in coronary heart disease. Acta Med Scand 176: 563
Baptista J and Pike MC (1977) Exact two-sided confidence limits for the odds ratio in a 2 × 2 table. Applied Stat 26: 214–220
Bjerkelund CJ (1957) The effect of long-term treatment with dicoumarol in myocardial infarction. Acta Med Scand 158 [Suppl 330]:
Borchgrevink CF (1960) Long-term anticoagulant therapy in angina pectoris and myocardial infarction. Acta Med Scand [Suppl 359]
Breddin K, Loew D, Lechner K et al. (1980) Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis 9: 325
British Medical Research Council (1964) An assessment of long-term anticoagulant administration after cardiac infarction. Br Med J 2: 837
Clausen J, Andersen PE, Andresen P, et al. (1961) Langtids-antikoagulansbehandling efter akut hjerteinfarkt. Ugeskr Laeger 123: 987
Conrad LL, Kyriacopoulos JD, Wiggins CW et al. (1964) Prevention of recurrences of myocardial infarction. Arch Intern Med 114: 348
Dale J (1976) Arterial thromboembolic complications in patients with Starr-Edwards aortic ball balve prostheses. Am Heart J 91: 653
Dale J (1977) Arterial thromboembolic complications in patients with Bjork-Shiley and Lillehei-Kaster aortic disc valve prostheses. Am Heart J 93: 715
Dale J, Myhre E, Storstein O, et al. (1977) Prevention of arterial thromboembolism with acetylalicylic acid. A controlled clinical study in patients with aortic ball valves. Am Heart J 94: 101
Duxbury BMcD (1982) Therapeutic control of anticoagulant treatment. Br Med J 284: 702
Ebert RV, Borden CW, Hipp HR et al. (1969) Long-term anticoagulant therapy after myocardial infarction. JAMA 207: 2263
EPSIM Research Group (1982) A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med 307: 701
Harvald B, Hilden T, Lund E (1962) Long-term anticoagulant therapy after myocardial infarction. Lancet 11: 626
Loeliger EA (1981) Oral anticoagulation in the secondary prevention of myocardial infarction. Acta Med Scand 210 [Suppl. 651]: 3
Loeliger EA (1983) A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med 308: 282
Loeliger EA, Lewis SM (1982) Progress in laboratory control of oral anticoagulants. Lancet 2: 318
Loeliger EA, Hensen A, Kroes F, et al. (1967) A double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 182: 549
Lovell RHH, Denborough MA, Nestel PJ et al. (1967) A controlled trial of long-term treatment with anticoagulants after myocardial infarction in 412 male patients. Med J Aust 2: 97
MacMillan RL, Brown KWG, Watt DL (1960) Long-term anticoagulant therapy after myocardial infarction. Can Med Assoc J 83: 567
Meuwissen OJAT, Vervoorn AC, Cohen O, et al. (1969) Double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 186: 361
Mitchell JRA (1981) Anticoagulants in coronary heart disease — retrospect and prospect. Lancet 1: 257
Poller L (1982) Anticoagulants reassessed. Br Med J 284: 1425
Rozenberg MC, Kronenberg H, Firkin BG (1965) “Thrombotest” and prothrombin time: a controlled clinical trial. Aust Ann Med 14:3
Seaman AJ, Griswold HE, Reaume RB et al. (1969) Long-term anticoagulant prophylaxis after myocardial infarction. N Engl J Med 281: 115
Sixty-Plus Reinfarction Study Research Group (1980) A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 2: 989
Sixty-Plus Reinfarction Study Research Group (1982) Risks of longterm oral anticoagulant therapy in elderly patients after myocardial infarction Lancet 1: 64
Sørensen OH, Friis T, Jorgensen AW, et al. (1969) Anticoagulant treatment of acute coronary thrombosis. Acta Med Scand 185: 65
Thomas DG and Gart JJ (1977) A table of exact confidence limits for differences and ratios of two proportions and their odds ratio. J Am Stat Assoc 72: 73
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Spriger-Verlag Berlin Heidelberg
About this paper
Cite this paper
Loeliger, E.A. (1983). Oral Anticoagulants and/or Aspirin. In: Roskamm, H. (eds) Prognosis of Coronary Heart Disease Progression of Coronary Arteriosclerosis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69052-5_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-69052-5_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69054-9
Online ISBN: 978-3-642-69052-5
eBook Packages: Springer Book Archive